TipHub

₹8,071.5

▼ -96.38 -1.18%

As of 28 Jul 2026 · delayed

NSE Listed · Healthcare

Astrazeneca Pharma India Ltd. (ASTRAZEN)

Volume: 1,773Avg Vol 1W: 5,924Avg Vol 1M: 7,78052W Range:₹7,551.5₹9,849.5
NSE BSE www.astrazeneca.in AI Report
Key Ratios
Checked just now
Market Cap—
Current Price₹8,071.5
Previous Close₹8,167.88
High / Low (52w)₹9,849.5 / ₹7,551.5
Volume1,773
Avg Vol (1W)5,924
Avg Vol (1M)7,780
Stock P/E449.67
Book Value₹349.12
Dividend Yield—
ROE—
ROA—
Revenue (TTM)₹2,276 Cr
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value₹2
EPS (TTM)₹17.95
P/B23.12
Debt / Equity—
50 DMA₹8,362.14
200 DMA₹8,645.48
Day change-1.18%
Price Chart
₹8,071.5▼ 9.79% · 1Y
₹9828₹77662.6L
2025-07-29
2026-07-28

20-day avg volume: 6K shares

Pros
  • Revenue grew 31% YoY.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 450.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹388 Cr₹408 Cr₹440 Cr₹480 Cr₹526 Cr₹559 Cr₹612 Cr₹579 Cr
EBITDA₹43 Cr₹51 Cr₹76 Cr₹85 Cr₹76 Cr₹79 Cr₹46 Cr₹61 Cr
Net Profit₹-12 Cr₹38 Cr₹31 Cr₹58 Cr₹56 Cr₹54 Cr₹33 Cr₹45 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹745 Cr₹845 Cr₹826 Cr₹820 Cr₹1,029 Cr₹1,330 Cr₹1,757 Cr₹2,304 Cr
EBITDA₹73 Cr₹115 Cr₹128 Cr₹84 Cr₹175 Cr₹204 Cr₹255 Cr₹262 Cr
Net Profit₹54 Cr₹72 Cr₹93 Cr₹62 Cr₹99 Cr₹162 Cr₹116 Cr₹188 Cr
EPS21.828.937.324.639.764.646.375.01
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹562 Cr₹706 Cr₹775 Cr₹857 Cr₹985 Cr₹1,078 Cr₹1,518 Cr₹1,989 Cr
Total Liabilities₹261 Cr₹342 Cr₹319 Cr₹345 Cr₹396 Cr₹366 Cr₹748 Cr₹1,116 Cr
Equity₹301 Cr₹364 Cr₹456 Cr₹511 Cr₹589 Cr₹712 Cr₹770 Cr₹873 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹137 Cr₹126 Cr₹99 Cr₹84 Cr₹130 Cr₹68 Cr
Investing₹173 Cr₹5 Cr₹18 Cr₹22 Cr₹31 Cr₹19 Cr
Financing₹-9 Cr₹-9 Cr₹-24 Cr₹-44 Cr₹-66 Cr₹-92 Cr
Free Cash Flow₹137 Cr₹126 Cr₹99 Cr₹84 Cr₹130 Cr₹68 Cr
Shareholding
Promoter 75% Institutions 8.76% Public 16.24%
About Astrazeneca Pharma India Ltd.

Healthcare · Drug Manufacturers - Specialty & Generic

AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally. It provides medicines for cardiovascular, renal, metabolic, and immunological conditions; oncology medicines under the TAGRISSO, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names. The company also offers medicines for diabetes; and clinical trial services. The company has a strategic collaboration with Leica Biosystems and Daiichi Sankyo Company, Limited for the development of an immunohistochemistry assay and an image analysis algorithm for the TROP2 NMR biomarker in non-small cell lung cancer. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.

www.astrazeneca.in ↗
Efficiency & Working Capital
ROCE25.5%
Interest Coverage57.2
Dividend Payout—
Debtor Days34 d
Inventory Days165 d
Payable Days126 d
Cash Conversion Cycle74 d
Working Capital Days199 d
Shareholding Details

As of 2026-06-30

Promoter75%
FII2.7%
DII6.1%
Institutions8.8%
Public16.2%
Promoter Pledge0%
No. of Shareholders29,338
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters75%75%75%75%75%75%75%75%75%75%75%75%
FIIs2.7%2.7%2.7%2.8%2.9%2.9%2.9%3%2.7%2.7%2.8%2.7%
DIIs2.4%2.8%3.8%5%5.1%5.2%4.7%4.6%5.3%5.6%5.8%6.1%
Public19.9%19.6%18.5%17.2%17%16.9%17.5%17.4%17%16.7%16.4%16.2%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders32,38029,03229,41827,16927,61527,32232,46634,37832,91431,55129,00729,338
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Astrazeneca Pharmaceuticals AbShareholding of Promoter and Promoter Group75%1.88 Cr
Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund(various Schemes)Public Shareholding2.9%7,22,443
Tejas Bhalchandra TrivediPublic Shareholding2.7%6,69,078
Shivani Tejas TrivediPublic Shareholding2.3%5,83,606
Icici Prudential - Various SchemesPublic Shareholding1.4%3,46,441
Bandhan - Various SchemesPublic Shareholding1.3%3,20,087
Prashant JainPublic Shareholding1.1%2,76,000
Astrazeneca AbShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Shilpa Divekar NirulaChairman & Independent Directo2026
Praveen Rao AkkinepallyManaging Director / Business Unit Head2026
Bhavana AgrawalExecutive Director / Whole Time Director / CFO2026
Revathy AshokIndependent Non Exe. Director2026
MONICA WIDHANIIndependent Non Exe. Director2026
Hooi Bien ChuahNon Executive Director2026
Tanya SanishCompany Sec. & Compli. Officer2026
Segments — Product
SegmentRevenueShare
Tablets₹1,046 Cr48.5%
Injectables₹1,060 Cr49.1%
Inhalation₹37 Cr1.7%
Powder₹14 Cr0.6%
Segments — Geography
RegionRevenueShare
India₹2,158 Cr94.8%
Outside India₹118 Cr5.2%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹2555
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-31Dividend (36/- per share)Final
dividend2026-07-31₹36 (1800%)Final
dividend2025-07-18₹32 (1600%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202570091,2661,328
202570091,1621,223
20250000105105
Company Information
Incorporated1979
ChairmanShilpa Divekar Nirula
AuditorPrice Waterhouse Chartered Accountants LLP
Investor Email[email protected]
🌐 www.astrazeneca.in ↗

📍 Blk N1 12th Flr Manyata Embass, Rachenahalli Outer Ring Road, Bangalore, Karnataka, 560045

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Aspire & Innovative Advertising Ltd.Asian Star Company Ltd.Astec Lifesciences Ltd.Aster DM Healthcare Ltd.Astral LimitedAstra Microwave Products Ltd.Astron Paper & Board MillAtal Realtech LimitedAtam Valves LimitedATC Energies System Ltd.Adani Total Gas LimitedAther Energy LimitedAll “A” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search